To Assess the Safety, Tolerability and Pharmacokinetic Properties of Niclosamide Injectable (DWRX2003) Which is the Treatment of COVID-19 in Healthy Volunteers.
Clinical trial NCT04749173 · COMPLETED
Trial details
- NCT number
- NCT04749173
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-21
- Primary completion
- 2021-06-18
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.